Eikon Therapeutics, Inc. (EIKN)
NASDAQ: EIKN · Real-Time Price · USD
14.38
-0.16 (-1.10%)
At close: Mar 6, 2026, 4:00 PM EST
14.00
-0.38 (-2.64%)
After-hours: Mar 6, 2026, 6:18 PM EST
Eikon Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Selling, General & Admin | 63.29 | 55.81 | 58.48 |
| Research & Development | 235.95 | 204.54 | 207.26 |
| Operating Expenses | 299.24 | 260.34 | 265.74 |
| Operating Income | -299.24 | -260.34 | -265.74 |
| Interest Expense | -0.89 | -0.03 | -0.04 |
| Interest & Investment Income | 14.95 | 16.56 | 23.74 |
| Other Non Operating Income (Expenses) | -0.02 | -0 | 0.04 |
| Pretax Income | -309.52 | -243.81 | -242 |
| Net Income | -309.52 | -243.81 | -242 |
| Net Income to Common | -318.91 | -243.81 | -242 |
| Shares Outstanding (Basic) | 3 | 3 | 2 |
| Shares Outstanding (Diluted) | 3 | 3 | 2 |
| Shares Change (YoY) | - | 24.34% | - |
| EPS (Basic) | -113.67 | -96.77 | -119.43 |
| EPS (Diluted) | -113.67 | -96.77 | -119.43 |
| Free Cash Flow | -256.73 | -219.6 | -219.36 |
| Free Cash Flow Per Share | -91.50 | -87.16 | -108.26 |
| EBITDA | -281.99 | -245.34 | -254.31 |
| D&A For EBITDA | 17.25 | 15.01 | 11.43 |
| EBIT | -299.24 | -260.34 | -265.74 |
Source: S&P Capital IQ. Standard template.
Financial Sources.